menu search

Rocket pharmaceuticals shares rise on fda fast-track designation for heart disease treatment

Shares of Rocket Pharmaceuticals RCKT, +0.17% gained 2.3% premarket on Thursday after the late-stage biotech <...

June 8, 2023, 8:25 am

Vera therapeutics to participate in the 44th annual goldman sachs global healthcare conference

BRISBANE, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on dev...

June 8, 2023, 8:00 am

Idna: continues to underperform, but with long-term potential

I rate IDNA a Hold due to its focus on biotech stocks with long-term growth potential in a rapidly grow...

June 8, 2023, 4:03 am

Msos: cannabis etf poised to underperform alongside a declining industry

The cannabis industry faces uncertainty due to federal legalization hurdles and increasing regulation, potentially hindering growth in the near term. ...

June 7, 2023, 3:51 pm

biotech stock falls on late-stage study

FibroGen Inc (NASDAQ:FGEN) stock is sliding today, after the biotech company announced disappointing re...

June 7, 2023, 10:29 am

3 biotech stocks that could skyrocket in the next 12 months

Navigating the turbulent waters in the biotech space is no mean feat. With the sector's inherent volati...

June 7, 2023, 8:55 am

Coya therapeutics stock gains on new data from alzheimer's study

Shares of Coya Therapeutics Inc. COYA, +3.33% gained 12% premarket on Wednesday after the clinical-stage biote...

June 7, 2023, 8:40 am

Is invesco dynamic biotechnology & genome etf (pbe) a strong etf right now?

Launched on 06/23/2005, the Invesco Dynamic Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Healt...

June 7, 2023, 7:33 am

Vir biotechnology announces multiple abstracts highlighting new hepatitis b and d data accepted for presentation at easl™ congress 2023

– Data support the potential impact of VIR-2218 and VIR-3434 in addressing both HBV and HDV and underscore the Company’s confidence in its approac...

June 7, 2023, 6:13 am

Cogent biosciences announces pricing of upsized public offering of shares of common stock

WALTHAM, Mass. and BOULDER, Colo., June 06, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on deve...

June 7, 2023, 12:25 am

Moderna, pfizer hit with new patent lawsuits over covid vaccines

biotech firm Promosome LLC sued Moderna , Pfizer and BioNTech , in federal court in San Diego, Californ...

June 6, 2023, 5:16 pm

Why shares of outlook therapeutics rose tuesday

Outlook, a clinical-stage biotech, is awaiting potential approval for a wet AMD therapy. The therapy has a PDUFA date of Aug. 29 from the FDA....

June 6, 2023, 1:59 pm

Arrowhead: biotech innovation on display

Arrowhead is a promising biotech company with a strong platform and pipeline of drugs targeting various...

June 6, 2023, 11:55 am

Mustgrow biologics: revolutionizing agriculture with natural biologic solutions

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF), a cutting-edge biotech company, is making waves in ...

June 6, 2023, 11:00 am

3 biotech stocks to sell in june before they crash and burn

The biotechnology sector has seen better days. From the heady days of the pandemic when companies were racing to develop a vaccine against Covid-19, t...

June 6, 2023, 9:11 am

Michael brush: biotech stocks could soon get a m&a boost. here are 3 likely takeover plays.

Big pharma will be looking to acquire companies with promsing new medicines. Read Full Story The post Michael Brush: ...

June 5, 2023, 7:05 pm

Fibrogen: several pamrevlumab data releases could change scope of biotech

FibroGen, Inc. results from the phase 3 LELANTOS-1 study, using pamrevlumab for the treatment of patients with non-ambulatory Duchenne Muscular Dystro...

June 5, 2023, 3:27 pm

Pds biotechnology post-asco conference call tomorrow, june 6, at 8 a.m. et

FLORHAM PARK, N.J., June 05, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing ...

June 5, 2023, 2:52 pm

Allakos announces upcoming presentation on lirentelimab and ak006 mast cell inhibition at the european academy of allergy and clinical immunology (eaaci) hybrid congress 2023

SAN CARLOS, Calif., June 05, 2023 (GLOBE NEWSWIRE) — Allakos Inc. (Nasdaq: ALLK), a clinical-stage biotechnology company developing therapeutics whi...

June 5, 2023, 11:02 am

Ocugen, inc. announces business advisory board

MALVERN, Pa., June 05, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...

June 5, 2023, 11:02 am


Search within

Pages Search Results: